New drug pipeline monitor. : H79-5E-PDF
"The New Drug Pipeline Monitor (NDPM) provides information on drugs currently under development that may have an impact on future drug plan expenditures in Canada. This publication contains a select list of pipeline drugs that are in Phase III clinical trials or under review by the US Food and Drug Administration (FDA) and that demonstrate the potential to have a significant clinical impact. The BioPharm Insight database is the main data source for this drug selection"--Executive summary, 2014.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.507462&sl=1
| Ministère/Organisme | Canada. Patented Medicine Prices Review Board. |
|---|---|
| Titre | New drug pipeline monitor. |
| Type de publication | Série |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Suivi de | Meds pipeline monitor ... ; 2562-3834 ; Began with 2018. |
| Format | Électronique |
| Note(s) | "National Prescription Drug Utilization Information System (NPDUIS)." Issued also in French under title: L'observateur des médicaments émergents. |
| Information sur la publication | Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2007-2015. |
| Chronologie | Began with 2007; ceased with 2015. |
| Périodicité | Annual (Irregular) |
| ISSN | 2292-3136 |
| Numéro de catalogue |
|
| Descripteurs | Drugs Research and development |
| Numéros | 2015 Cliquer pour agrandir
2014 Cliquer pour agrandir
|